What Happened?
Watertown, MA-based Forma Therapeutics Appointed John Bishop as Chief Technology Officer
About the Company
At FORMA, patients are our purpose. We are dedicated to delivering transformative medicines to patients with cancer and rare diseases. We are a fully-integrated, privately-held clinical stage biopharmaceutical company. A leader in metabolism, epigenetics and protein homeostasis focused on the discovery, development and commercialization of transformative medicines. Our proprietary R&D platform combines deep biology insight, chemistry expertise and clinical development capabilities to create differentiated drug candidates. We have delivered high-value clinical candidates to our partners and generated a broad proprietary portfolio of internal programs, ranging from pre-clinical to pivotal-stage, with the potential to provide profound patient benefit in hematologic, oncologic and metabolic indications.
About the Person
John Bishop is Chief Technology Officer at Lyra Therapeutics. Previously, John held various senior IT leadership roles in the industry.
Info Source
News
Short Profile